AVDL
Avadel Pharmaceuticals Plc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$21.64
+0.00%Latest reported
- Last report date
- Aug 7, 2025
- EPS actual
- $0.10
- EPS estimate
- $0.02
- Revenue actual
- $68.1M
- Revenue estimate
- $73.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +111.6%
- Revenue beats (12Q)
- 0
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2025 | $0.02 | $0.10 | Beat 400.00% | $68.1M |
| May 7, 2025 | -$0.07 | -$0.05 | Beat 28.57% | $52.5M |
| Mar 3, 2025 | -$0.05 | -$0.05 | In line | $50.4M |
| Aug 8, 2024 | -$0.17 | -$0.14 | Beat 17.65% | $41.5M |
| May 8, 2024 | -$0.25 | -$0.30 | Miss -20.00% | $27.2M |
| Mar 4, 2024 | -$0.28 | -$0.32 | Miss -14.29% | $19.5M |
| May 4, 2023 | -$0.37 | -$0.48 | Miss -29.73% | — |
| Nov 9, 2022 | -$0.22 | -$0.33 | Miss -50.00% | — |
| Aug 9, 2022 | -$0.41 | -$0.50 | Miss -21.95% | — |
| Mar 17, 2022 | -$0.42 | -$0.38 | Beat 9.52% | — |
| Mar 9, 2021 | -$0.28 | -$0.24 | Beat 14.29% | $0.00 |
| Mar 12, 2020 | -$0.25 | -$0.07 | Beat 72.00% | $11.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 5, 2026